PPARG and cardiac hypertrophy: In this respect it might be significant that rosiglitazone-induced myocardial hypertrophy, an early hallmark and important risk factor for the development of heart failure [9], still occurs in cardiomyocyte-specific PPARγ knock-out mice [10].